Mapping strategies for premature ventricular contractions-activation, voltage, and/or pace map

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• A high burden of premature ventricular contractions (PVCs) is linked to increased cardiovascular mortality, palpitations, reduced physical capacity, and PVC-induced cardiomyopathy.
• Catheter ablation is recommended as a Class I option for symptomatic idiopathic outflow tract PVCs and suspected PVC-induced cardiomyopathy, proving more effective than medical therapy alone.

Purpose of the Study:

• To outline the importance of careful planning and advanced mapping techniques for optimizing catheter ablation outcomes in patients with high PVC burden.
• To discuss the role of electrocardiogram (ECG) analysis and pharmacological provocation in predicting PVC origin and improving procedural success.

Main Methods:

• Utilizing 12-lead ECG to predict the most likely PVC origin.
• Employing pharmacological provocation to increase PVC burden when spontaneous PVCs are insufficient.
• Leveraging high-density mapping systems, including activation mapping and pace mapping, for accurate arrhythmia localization.
• Integrating various mapping information through automated systems for enhanced efficiency.

Main Results:

• High-density mapping systems have significantly improved the accuracy and efficiency of arrhythmia mapping.
• Activation mapping visualizes the earliest activation site, while pace mapping identifies target areas by comparing stimulated QRS complexes with clinical PVCs.
• A combination of activation and pace mapping is currently the preferred approach for PVC mapping, maximizing procedural outcomes.

Conclusions:

• Catheter ablation is a highly effective treatment for high PVC burden, especially when guided by precise mapping techniques.
• Predictive ECG analysis and advanced mapping strategies, including integrated systems, are crucial for successful PVC ablation.
• Continued advancements in mapping technology enhance the precision and efficiency of treating PVC-related cardiovascular conditions.